0 Commentaires
0 Parts
933 Vue
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Blogs
-
Forums
-
Connectez-vous pour aimer, partager et commenter!
-
Precision Medicine Market Expansion Strategies and InsightsThe healthcare landscape is undergoing a seismic shift. We are moving away from the traditional "one-size-fits-all" approach and entering an era where your treatment is as unique as your DNA. This evolution is central to the Precision Medicine Market, a sector that is redefining how we diagnose, treat, and prevent diseases. At its core, precision medicine (often called personalized...0 Commentaires 0 Parts 677 Vue
-
Precision Medicine Market Opportunities Across Healthcare SectorsFor decades, medicine followed a "one size fits all" philosophy. If you had a specific ailment, you received the same pill as everyone else with that diagnosis. Some people got better, some didn’t, and others suffered from side effects that were often worse than the original problem. Today, we are witnessing a paradigm shift. The Precision Medicine Market is moving away from...0 Commentaires 0 Parts 55 Vue
-
Precision Medicine Market Set for Strong CAGR Amid AI and Biomarker InnovationsThe Precision Medicine market has moved from scientific concept to clinical reality over the past decade. Instead of prescribing treatments based solely on broad population averages, healthcare providers increasingly tailor therapies according to an individual’s genetic profile, environment, and lifestyle. The result? More targeted interventions, improved outcomes, and fewer...0 Commentaires 0 Parts 1KB Vue
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Commentaires 0 Parts 1KB Vue
-
Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...0 Commentaires 0 Parts 1KB Vue
-
High Potency Active Pharmaceutical Ingredients Market to Reach USD 66.38 Billion by 2033, Growing at 9.37% CAGRMarket Overview The global high potency active pharmaceutical ingredients market size was valued at USD 29.64 billion in 2024 and is projected to grow from USD 32.42 billion in 2025 to reach USD 66.38 billion in 2033, growing at a CAGR of 9.37% during the forecast period (2025–2033). The global High Potency Active Pharmaceutical Ingredients market...0 Commentaires 0 Parts 3KB Vue
-
Microsurgery Market to Reach USD 3.88 Billion by 2033, Growing at 5.13% CAGRMicrosurgery Market Overview The global microsurgery market size was valued at USD 2.47 billion in 2024 and is expected to grow from USD 2.60 billion in 2025 to USD 3.88 billion by 2033, growing at a CAGR of 5.13% during the forecast period (2025-2033). Download Exclusive Research Report PDF Sample: (Including Full TOC, List of Tables &...0 Commentaires 0 Parts 4KB Vue
-
Neurofibromatosis Drugs Market Innovation and Pipeline AnalysisNeurofibromatosis is a rare genetic disorder characterized by the growth of tumors along nerves in the skin, brain, and other parts of the body. The increasing prevalence of rare neurological disorders, advancements in targeted therapies, and rising investments in orphan drug development are driving significant growth in the neurofibromatosis drugs industry. Pharmaceutical companies are...0 Commentaires 0 Parts 16 Vue
-
TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...0 Commentaires 0 Parts 958 Vue
-
Whole Exome Sequencing Market to Reach USD 14.02B by 2033, Growing at 21.5% CAGRWhole Exome Sequencing Market Overview The global whole exome sequencing market size was valued at USD 2.43 billion in 2024 and is anticipated to grow from USD 2.95 billion in 2025 to reach USD 14.02 billion in 2033, growing at a CAGR of 21.5% during the forecast period (2025–2033). Download Exclusive Research Report PDF Sample: (Including Full TOC,...0 Commentaires 0 Parts 3KB Vue
© 2026 Khajiit Nation
French
French
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek